SCOHIA PHARMA, Inc.
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-04-10 | Neurocrine Switzerland GmbH | SCO-483 / NBI-1852737 | USD 20,000,000 | Not disclosed | Not disclosed | Preclinical |